Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome
Indian Journal of Endocrinology and Metabolism · 2025-05 · 29 (3) · 319-324
DOI: 10.4103/ijem.ijem_491_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 28.06.2025. Verfasst von Sukirti Misra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Anti-Mullerian hormone (AMH) is a key regulator of ovarian folliculogenesis. Obesity, insulin resistance (IR), hyperandrogenism, and gonadotropins have an inconclusive role in the relation and regulation of AMH to polycystic ovarian syndrome (PCOS).
Methods
PCOS cases ( n = 80) and matched controls ( n = 80) were evaluated with AMH levels and correlated with age, body mass index (BMI), insulin levels, IR, insulin sensitivity (IS), gonadotropins, and androgens.
Results
Women with PCOS had significantly higher levels of AMH than controls (5.79 ± 4.00 ng/mL in obese cases vs 2.88 ± 2.38 ng/mL in obese controls, P = 0.006; 6.59 ± 4.13 ng/mL in lean cases vs 3.62 ± 2.04 ng/mL in lean controls, P < 0.001). AMH levels did not differ significantly amongst cases with respect to hyperandrogenism, BMI, and PCO morphology. However, women with PCOS who had irregular cycles had significantly greater AMH levels than those with regular menstrual cycles (6.27 ± 4.03 ng/mL vs 2.36 ± 2.02 ng/mL, P = 0.031). There was a negative correlation between AMH and BMI in all four groups, but reached significance only in lean PCOS. AMH did not correlate with insulin levels, HOMA-IR, or IS in any of the four groups. In lean PCOS, AMH correlated significantly with DHEAS ( r = 0.424), androstenedione ( r = 0.413), testosterone ( r = 0.502), and SHBG ( r = 0.412). In obese PCOS, AMH associated positively with androstenedione ( r = 0.490) and testosterone ( r = 0.402).
Conclusion
BMI, IR, and androgens might differentially regulate AMH levels in lean and obese PCOS. AMH levels were higher in the subset of PCOS with irregular menses than in those with regular cycles; thus, higher AMH indicates a more severe disease state in PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India.
Zitieren
APA
Misra, S., Gada, J. V., Chauhan, Y. V., Rahate, S. S., Karde, B. D., Varthakavi, P. K., & Bhagwat, N. M. (2025). Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome. Indian Journal of Endocrinology and Metabolism, 29(3), 319-324. https://doi.org/10.4103/ijem.ijem_491_24
Vancouver
Misra S, Gada JV, Chauhan YV, Rahate SS, Karde BD, Varthakavi PK, et al. Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome. Indian Journal of Endocrinology and Metabolism. 2025;29(3):319-324. doi:10.4103/ijem.ijem_491_24
BibTeX
@article{Misra2025,
author = {Misra, Sukirti and Gada, Jugal V and Chauhan, Yash V and Rahate, Sachin S and Karde, Bhakti D and Varthakavi, Premlata K and Bhagwat, Nikhil M},
title = {Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome},
journal = {Indian Journal of Endocrinology and Metabolism},
year = {2025},
volume = {29},
number = {3},
pages = {319--324},
doi = {10.4103/ijem.ijem_491_24}
}
EUVIMED